Semaglutide is a GLP-1 medication approved by the US Food and Drug Administration (FDA) that controls blood sugar levels in people with type 2 diabetes, reduces the risk of heart attack and stroke in people with heart disease and type 2 diabetes or obesity, and promotes weight loss in people with overweight and obesity
Key Takeaways Thirst is an indirect effect, not a primary side effect Reduced appetite can lower fluid intake Digestive symptoms may increase fluid loss Dry mouth can heighten thirst perception Medical guidance helps maintain hydration balance Why You Might Feel Thirsty on Zepbound Zepbound helps curb appetite and slows digestion by acting on GLP-1 and GIP receptors
These therapies also come with tradeoffs, including gastrointestinal side effects and the potential for nutrient gaps if food intake drops too low
Chitimus DM, Popescu MR, Voiculescu SE, Panaitescu AM, Pavel B, Zagrean L, Zagrean AM
Germany records a slightly lower rate because evidence and procurement expectations are more formal
Too often, when a patient is given a diagnosis of dementia or Alzheimers disease, the neurological workup and treatment attempts stop